缺氧缺血性脑病变的新兴治疗策略:关注认知结果
Kethely L Marques1, Victor Rodrigues2, Cassiana T N Balduci1,3
1Laboratory of Neurobiology, Pharmacology and Psychobiology Department, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Frontiers in pharmacology
|March 12, 2024
概括
低毒性缺血性脑病变 (HIE) 对中枢神经系统发育构成风险. 虽然一些药物在动物模型中表现有前途,但临床试验显示对HIE认知缺陷的有效性有限,需要进一步研究.
科学领域:
- 新生儿神经病学 新生儿神经病学
- 发育神经科学的发展神经科学.
- 临床药理学 临床药理学
背景情况:
- 围产期缺氧缺血症 (HIE) 是对中枢神经系统 (CNS) 发育的重大威胁,导致显著的死亡率和长期的神经缺陷.
- 尽管医学取得了进展,但HIE的发病率仍然很高,运动缺陷在早期出现,认知障碍在晚些时候出现,需要长时间的监测.
研究的目的:
- 本综述探讨了对缺氧缺血性脑病变 (HIE) 的潜在治疗干预措施,特别是针对认知缺陷.
- 该研究评估了在随机临床试验 (RCT) 中测试的药物治疗方法,以评估它们对与HIE相关的认知结果的影响.
主要方法:
- 进行了随机临床试验 (RCT) 的系统搜索.
- 包括专注于HIE药物治疗及其对认知结果的影响的研究.
主要成果:
- 研究中的药物包括红素,黑激素,硫酸,托皮拉和维生素C/ibuprofen组合.
- 虽然动物模型表明神经保护性益处,但RCT在缓解HIE诱导的认知障碍方面表现得不完全有效.
结论:
- 目前来自RCT的证据并不完全支持研究药物对HIE认知缺陷的有效性.
- 更严格的随机临床试验对于建立HIE相关认知障碍的标准化和有效治疗方法至关重要.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
01:22Alzheimer's Disease: Treatment
188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188